Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Veterinary
Safety Information
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Our Role
Veterinary Medicines Information
Safety Information
How We Monitor Safety
Adverse Reaction/Event Reporting
Information on pharmacovigilance for marketing authorisation holders and applicants
Annual Pharmacovigilance Reports
Pharmacovigilance inspections
Safety Notices
Regulatory Information
Special Topics
Contact details
Veterinary News & Events
Scientific Animal Protection
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Recall notice for RenuTend suspension for injection for horses, EU/2/22/282/001
Notice type:
Recall
Date:
04/10/2023
We wish to advise you that two batches of RenuTend suspension for injection for horses, EU/2/22/282/001 are being recalled with immediate effect.
This recall is going to veterinary level.
The reason for the recall is due to deviations in GMP manufacturing. This is a voluntary recall and there is no need to contact owners of horses that have been treated with these batches.
Veterinarians can download a copy of the
veterinary recall letter
.
Product name or type:
RenuTend suspension for injection for horses
Authorisation Number:
EU/2/22/282/001
Serial Or Batch Number And Expiry Date:
Batch T36093/05, expiry June 2024
Batch T36105/04, expiry February 2025
Authorisation Holder:
Boehringer Ingelheim Animal Health UK Limited
Recall Classification:
Veterinary level
Target Audience:
Veterinary Surgeons
Actions To Be Taken:
Veterinarians are requested to please perform the following actions:
1. Please check your inventory and immediately quarantine any units of these batches which you have in your possession, or that are returned to you.
2. Please complete the returns form attached to the recall letter detailing the number of units to be returned and return this form to Customer Services via email at CSServiceQueries.bra@boehringer-ingelheim.com
3. The company's customer service team will contact you to arrange collection of the units.
Animal owners:
If you have this product in your possession and have any concerns, please contact your veterinary hospital.
In line with standard pharmacovigilance procedure for any veterinary medicinal product, should any horse treated with RenuTend suspension for injection for horses experience any adverse event, please contact vetenquiries@boehringer-ingelheim.com.
« Back
Date Printed: 27/04/2024